Idiopathic Pulmonary Fibrosis News

What is idiopathic pulmonary fibrosis and when was Katie Price's mum Amy diagnosed? Causes, symptoms and ... - The Sun



The Sun
 
What is idiopathic pulmonary fibrosis and when was Katie Price's mum Amy diagnosed? Causes, symptoms and ... 
The Sun
The condition is a build-up of scar tissue on the lungs that makes breathing increasingly difficult. It typically affects those around the age of 70-75, and is rare for individuals under the age of 50. Some people respond well to treatment, but others ...
Watch the moment heartbroken Katie Price offers her own lung to her dying terminally ill mum after revealing Amy ... OK! Magazine

all 3 news articles » 


With only 100000 people affected in the United States, idiopathic pulmonary fibrosis, or IPF, is a diagnosis that ... - Reader's Digest



Reader's Digest
 
With only 100000 people affected in the United States, idiopathic pulmonary fibrosis, or IPF, is a diagnosis that ... 
Reader's Digest
Mark developed a case of pneumonia that landed him in the hospital for five days, and it was there he received the news he never saw coming: Mark had idiopathic pulmonary fibrosis, an incurable rare lung condition in which scar tissue grows in the ...
5 Ways Idiopathic Pulmonary Fibrosis Impacts Daily Life Pulmonary Fibrosis News

all 2 news articles » 


Idiopathic Pulmonary Fibrosis - Pulmonary Fibrosis News



Pulmonary Fibrosis News
 
Idiopathic Pulmonary Fibrosis 
Pulmonary Fibrosis News
Pulmonary fibrosis (PF) is a disease of the respiratory system, caused by the thickening and stiffening of lung tissue that leads to the formation of scar tissue. When physicians are unable to identify the root cause of the disease, it is called ...
Baseball Legend, Country Singer to Join Renowned Scientists at Pulmonary Fibrosis Summit Lung Disease News

all 23 news articles » 


Focus on Idiopathic Pulmonary Fibrosis: Interview with Dr Low Su Ying at the ERS Congress 2017 - Biotechin.Asia



Biotechin.Asia
 
Focus on Idiopathic Pulmonary Fibrosis: Interview with Dr Low Su Ying at the ERS Congress 2017 
Biotechin.Asia
Dr Low is one of the few experts on idiopathic pulmonary fibrosis (IPF) in Singapore, and during our talk, she shared local insights on IPF, including factors such as diagnosis/misdiagnosis and treatment. The diagram illustrates the lung scarring with ...

 


Europe Idiopathic Pulmonary Fibrosis Market - Forecast & Analysis 2017 - Research and Markets - Business Wire (press release)



Europe Idiopathic Pulmonary Fibrosis Market - Forecast & Analysis 2017 - Research and Markets 
Business Wire (press release)
The latest research provides comprehensive insights into Idiopathic Pulmonary Fibrosis pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast ...

and more » 


Global Idiopathic Pulmonary Fibrosis Market Expected to Reach $3569 Million by 2023 - Allied Market Research - PR Newswire (press release)



Medgadget (blog)
 
Global Idiopathic Pulmonary Fibrosis Market Expected to Reach $3569 Million by 2023 - Allied Market Research 
PR Newswire (press release)
According to a new report published by Allied Market Research, titled, "Idiopathic Pulmonary Fibrosis Market by Type of Drug: Global Opportunity Analysis and Industry Forecast, 2017-2023," the global idiopathic pulmonary fibrosis market was valued at ...
Idiopathic Pulmonary Fibrosis ? Companies Involved in Therapeutics Development (BLR Bio, FibroGen, FibroStatin ... Medgadget (blog)

all 4 news articles » 


Breathless: When IPF Strikes - Medscape



Medscape
 
Breathless: When IPF Strikes 
Medscape
Pulmonary fibrosis can have a number of etiologies. When tests reveal that there is no direct cause and the disease is progressive, physicians only then assign a diagnosis of idiopathic pulmonary fibrosis (IPF). A chronic disease, IPF has proven ...

 


Ofev Delays IPF Progression Beyond 52 Weeks, Results from TOMORROW Extension Trial Show - Pulmonary Fibrosis News



Pulmonary Fibrosis News
 
Ofev Delays IPF Progression Beyond 52 Weeks, Results from TOMORROW Extension Trial Show 
Pulmonary Fibrosis News
Long-term use of Boehringer Ingelheim's Ofev (nintedanib) prevents disease progression in patients with idiopathic pulmonary fibrosis (IPF), according to the latest results of the TOMORROW trial and its open-label extension. The study, ?Long-term ...

 


Charity cabaret event given the star treatment - The News



The News
 
Charity cabaret event given the star treatment 
The News
The event raised money for Action for Pulmonary Fibrosis (APF) ? a charity that focuses on improving the quality of life for patients suffering with IPF, as well as funding research into finding a cure. TV star and style guru Gok Wan hosted the event ...

 


Woman Who Watched 5 Family Members Die From Rare Lung Disease Searches for Answers: 'It Was Torment' - PEOPLE.com



PEOPLE.com
 
Woman Who Watched 5 Family Members Die From Rare Lung Disease Searches for Answers: 'It Was Torment' 
PEOPLE.com
During a disastrous period starting in 1996, Teresa Barnes of Memphis, Tennessee, lost her father, aunt and three uncles to idiopathic pulmonary fibrosis, or IPF syndrome, an incurable disease with no known cause which affects 30,000 to 40,000 new ...